Lipofilling with ex-vivo expanded adipose tissue-derived stem cells for cosmetic breast filling or for facial filling and/or rejuvenation
AssigneeStemform Aps
InventorStig-Frederik Trojahn KØLLE
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising ex-vivo expanded adipose tissue derived stem cell (ASC) or ex-vivo expanded adipose tissue-derived stem cells (ASC) mixed with harvested fat tissue at a ratio of 5,0×104−2,0×108 ASCs/mL fat; for example 1,0×105−2,0×107 and the use of ex-vivo expanded adipose tissue-derived stem cells or ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts as an agent for cosmetic breast filling/augmentation or for facial filling/rejuvenation.
Claims10
A composition comprising ex-vivo expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) mixed with harvested fat tissue at a ratio of 5,0×104−2,0×108 ASCs/mL fat.
Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts as a breast filling agent.
Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells as a facial filling agent.
Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells for cosmetic breast filling.
Use of ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells for cosmetic facial filling.
Cosmetic method of breast filling wherein adipose tissue-derived stem cell (ASC) enriched fat grafts is mixed with harvested fat tissue at a ratio of 5,0×104−2,0×108 ASCs/mL fat, and wherein the fat is injected as aliquots or as strings with a long needle horizontally (parallel to the body) by inserting the needle from several points around the areola margin and at several points at the inframammary fold in variable directions and planes to achieve an even and natural appearing distribution of the graft.
Cosmetic method of facial filling wherein expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) are mixed with harvested fat tissue at a ratio of 5,0×104−2,0×108 ASCs/mL fat or solved in PBS in order to evenly distribute the cells, and wherein the fat grafts are injected as aliquots or as strings with a long needle horizontally (parallel to the surface) to avoid damaging structures outside the target area and the needle is inserted from several points and in variable directions and planes to achieve an even and natural appearing distribution of the graft.
Cosmetic method of facial filling wherein expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) are mixed with harvested fat tissue at a ratio of 5,0×104−2,0×108 ASCs/mL fat or solved in PBS in order to evenly distribute the cells, and wherein the solved ASCs are injected in the dermis with a thin sharp needle and evenly distributed in the target area and the incision and injection sites are sutured and postoperative compression garments are applied to the donor sites and in some cases also to the recipient sites.
Cosmetic method of introducing an agent to the skin wherein the agent comprises ex-vivo expanded adipose tissue-derived stem cell enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells.
Cosmetic method of introducing an agent to the skin wherein the agent comprises ex-vivo expanded adipose tissue-derived stem cell (ASC) enriched fat grafts or ex-vivo expanded adipose tissue-derived stem cells (ASC) mixed with harvested fat tissue at a ratio of 5,0×104−2,0×108 ASCs/mL fat.
Dependencies are inferred from the claim text.